Trial Profile
A Phase Ib Study to Evaluate the Tolerability and Pharmacokinetics of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Selatinib (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Qilu Pharmaceutical
- 10 May 2016 New trial record